Amanote Research
Register
Sign In
Neoadjuvant Chemotherapy in the Management of Advanced Ovarian Cancer and Primary Cancer of the Peritoneum: Rationale and Results
doi 10.5772/55394
Full Text
Open PDF
Abstract
Available in
full text
Date
May 22, 2013
Authors
Maurie Markman
Publisher
InTech
Related search
Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: Latest Results and Place in Therapy
Therapeutic Advances in Medical Oncology
Oncology
Incorporating Robotic Surgery Into the Management of Ovarian Cancer After Neoadjuvant Chemotherapy
International Journal of Gynecological Cancer
Gynecology
Oncology
Obstetrics
Primary Debulking Surgery Versus Primary Neoadjuvant Chemotherapy for High Grade Advanced Stage Ovarian Cancer: Comparison of Survivals
Radiology and Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer. Who Really Benefits?
Australian and New Zealand Journal of Obstetrics and Gynaecology
Medicine
Gynecology
Obstetrics
Evaluating the Benefits of Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer: A Retrospective Study
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
Neoadjuvant Chemotherapy of Resectable Advanced Gastric Cancer
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
Intraperitoneal Chemotherapy for the Initial Management of Primary Epithelial Ovarian Cancer
Cochrane Database of Systematic Reviews
Intraperitoneal Chemotherapy for the Initial Management of Primary Epithelial Ovarian Cancer
Neoadjuvant Chemotherapy for Patients With Advanced Epithelial Ovarian Cancer: A Meta-Analysis
Scientific Reports
Multidisciplinary
